356 related articles for article (PubMed ID: 15814672)
21. Endogenous expression levels of autoantigens influence success or failure of DNA immunizations to prevent type 1 diabetes: addition of IL-4 increases safety.
Wolfe T; Bot A; Hughes A; Möhrle U; Rodrigo E; Jaume JC; Baekkeskov S; von Herrath M
Eur J Immunol; 2002 Jan; 32(1):113-21. PubMed ID: 11754351
[TBL] [Abstract][Full Text] [Related]
22. Glutamic acid decarboxylase epitope protects against autoimmune diabetes through activation of Th2 immune response and induction of possible regulatory mechanism.
Gong Z; Pan L; Le Y; Liu Q; Zhou M; Xing W; Zhuo R; Wang S; Guo J
Vaccine; 2010 May; 28(24):4052-8. PubMed ID: 20406664
[TBL] [Abstract][Full Text] [Related]
23. Immune response to glutamic acid decarboxylase correlates with insulitis in non-obese diabetic mice.
Tisch R; Yang XD; Singer SM; Liblau RS; Fugger L; McDevitt HO
Nature; 1993 Nov; 366(6450):72-5. PubMed ID: 8232539
[TBL] [Abstract][Full Text] [Related]
24. Pancreatic IL-4 expression results in islet-reactive Th2 cells that inhibit diabetogenic lymphocytes in the nonobese diabetic mouse.
Gallichan WS; Balasa B; Davies JD; Sarvetnick N
J Immunol; 1999 Aug; 163(3):1696-703. PubMed ID: 10415077
[TBL] [Abstract][Full Text] [Related]
25. Retroviral delivery of GAD-IgG fusion construct induces tolerance and modulates diabetes: a role for CD4+ regulatory T cells and TGF-beta?
Song L; Wang J; Wang R; Yu M; Sun Y; Han G; Li Y; Qian J; Scott DW; Kang Y; Soukhareva N; Shen B
Gene Ther; 2004 Oct; 11(20):1487-96. PubMed ID: 15343360
[TBL] [Abstract][Full Text] [Related]
26. GAD-reactive CD4+ Th1 cells induce diabetes in NOD/SCID mice.
Zekzer D; Wong FS; Ayalon O; Millet I; Altieri M; Shintani S; Solimena M; Sherwin RS
J Clin Invest; 1998 Jan; 101(1):68-73. PubMed ID: 9421467
[TBL] [Abstract][Full Text] [Related]
27. Plasmid DNAs encoding insulin and glutamic acid decarboxylase 65 have distinct effects on the progression of autoimmune diabetes in nonobese diabetic mice.
Weaver DJ; Liu B; Tisch R
J Immunol; 2001 Jul; 167(1):586-92. PubMed ID: 11418698
[TBL] [Abstract][Full Text] [Related]
28. Presence of diabetes-inhibiting, glutamic acid decarboxylase-specific, IL-10-dependent, regulatory T cells in naive nonobese diabetic mice.
You S; Chen C; Lee WH; Brusko T; Atkinson M; Liu CP
J Immunol; 2004 Dec; 173(11):6777-85. PubMed ID: 15557171
[TBL] [Abstract][Full Text] [Related]
29. Regulatory Th2-type T cell lines against insulin and GAD peptides derived from orally- and nasally-treated NOD mice suppress diabetes.
Maron R; Melican NS; Weiner HL
J Autoimmun; 1999 Jun; 12(4):251-8. PubMed ID: 10330296
[TBL] [Abstract][Full Text] [Related]
30. Systemic overexpression of IL-10 induces CD4+CD25+ cell populations in vivo and ameliorates type 1 diabetes in nonobese diabetic mice in a dose-dependent fashion.
Goudy KS; Burkhardt BR; Wasserfall C; Song S; Campbell-Thompson ML; Brusko T; Powers MA; Clare-Salzler MJ; Sobel ES; Ellis TM; Flotte TR; Atkinson MA
J Immunol; 2003 Sep; 171(5):2270-8. PubMed ID: 12928371
[TBL] [Abstract][Full Text] [Related]
31. Early Th1 response in unprimed nonobese diabetic mice to the tyrosine phosphatase-like insulinoma-associated protein 2, an autoantigen in type 1 diabetes.
Trembleau S; Penna G; Gregori S; Magistrelli G; Isacchi A; Adorini L
J Immunol; 2000 Dec; 165(12):6748-55. PubMed ID: 11120794
[TBL] [Abstract][Full Text] [Related]
32. Protection of NOD mice from type 1 diabetes after oral inoculation with vaccinia viruses expressing adjuvanted islet autoantigens.
Denes B; Krausova V; Fodor N; Timiryasova T; Henderson D; Hough J; Yu J; Fodor I; Langridge WH
J Immunother; 2005; 28(5):438-48. PubMed ID: 16113600
[TBL] [Abstract][Full Text] [Related]
33. Prevention of type I diabetes transfer by glutamic acid decarboxylase 65 peptide 206-220-specific T cells.
Kim SK; Tarbell KV; Sanna M; Vadeboncoeur M; Warganich T; Lee M; Davis M; McDevitt HO
Proc Natl Acad Sci U S A; 2004 Sep; 101(39):14204-9. PubMed ID: 15381770
[TBL] [Abstract][Full Text] [Related]
34. Co-delivery of pro-apoptotic BAX with a DNA vaccine recruits dendritic cells and promotes efficacy of autoimmune diabetes prevention in mice.
Li AF; Hough J; Henderson D; Escher A
Vaccine; 2004 Apr; 22(13-14):1751-63. PubMed ID: 15068859
[TBL] [Abstract][Full Text] [Related]
35. NK T cell-induced protection against diabetes in V alpha 14-J alpha 281 transgenic nonobese diabetic mice is associated with a Th2 shift circumscribed regionally to the islets and functionally to islet autoantigen.
Laloux V; Beaudoin L; Jeske D; Carnaud C; Lehuen A
J Immunol; 2001 Mar; 166(6):3749-56. PubMed ID: 11238616
[TBL] [Abstract][Full Text] [Related]
36. CD8+ T lymphocytes specific for glutamic acid decarboxylase 90-98 epitope mediate diabetes in NOD SCID mouse.
Sévère S; Gauvrit A; Vu AT; Bach JM
Mol Immunol; 2007 Apr; 44(11):2950-60. PubMed ID: 17336387
[TBL] [Abstract][Full Text] [Related]
37. GAD-alum immunotherapy in Type 1 diabetes mellitus.
Morales AE; Thrailkill KM
Immunotherapy; 2011 Mar; 3(3):323-32. PubMed ID: 21395375
[TBL] [Abstract][Full Text] [Related]
38. CD4(+) T cells from glutamic acid decarboxylase (GAD)65-specific T cell receptor transgenic mice are not diabetogenic and can delay diabetes transfer.
Tarbell KV; Lee M; Ranheim E; Chao CC; Sanna M; Kim SK; Dickie P; Teyton L; Davis M; McDevitt H
J Exp Med; 2002 Aug; 196(4):481-92. PubMed ID: 12186840
[TBL] [Abstract][Full Text] [Related]
39. Normal incidence of diabetes in NOD mice tolerant to glutamic acid decarboxylase.
Jaeckel E; Klein L; Martin-Orozco N; von Boehmer H
J Exp Med; 2003 Jun; 197(12):1635-44. PubMed ID: 12796471
[TBL] [Abstract][Full Text] [Related]
40. Characterization of antibody responses to endogenous and exogenous antigen in the nonobese diabetic mouse.
Koczwara K; Schenker M; Schmid S; Kredel K; Ziegler AG; Bonifacio E
Clin Immunol; 2003 Feb; 106(2):155-62. PubMed ID: 12672406
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
